Cargando…

Free fatty acid receptors as therapeutic targets for the treatment of diabetes

Nutrition regulates energy balance; however, dysfunction of energy balance can cause metabolic disorders, such as obesity and diabetes. Fatty acids are an essential energy source and signaling molecules that regulate various cellular processes and physiological functions. Recently, several orphan G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ichimura, Atsuhiko, Hasegawa, Sae, Kasubuchi, Mayu, Kimura, Ikuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222138/ https://www.ncbi.nlm.nih.gov/pubmed/25414667 http://dx.doi.org/10.3389/fphar.2014.00236

Ejemplares similares

Nutritional Signaling via Free Fatty Acid Receptors
por: Miyamoto, Junki, et al.
Publicado: (2016)

Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation
por: Kasubuchi, Mayu, et al.
Publicado: (2015)

Editorial: Obesity and Diabetes: Energy Regulation by Free Fatty Acid Receptors
por: Ichimura, Atsuhiko, et al.
Publicado: (2015)

Therapeutic Role and Ligands of Medium- to Long-Chain Fatty Acid Receptors
por: Hara, Takafumi, et al.
Publicado: (2014)

Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice
por: Miyamoto, Junki, et al.
Publicado: (2018)

Membrane progesterone receptor beta (mPRβ/Paqr8) promotes progesterone-dependent neurite outgrowth in PC12 neuronal cells via non-G protein-coupled receptor (GPCR) signaling
por: Kasubuchi, Mayu, et al.
Publicado: (2017)

Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease
por: Secor, Jordan D., et al.
Publicado: (2021)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)

Free Fatty Acid Receptor 1 Signaling Contributes to Migration, MMP-9 Activity, and Expression of IL-8 Induced by Linoleic Acid in HaCaT Cells
por: Manosalva, Carolina, et al.
Publicado: (2020)

Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
por: Sheng, Lili, et al.
Publicado: (2021)

The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer
por: Piesche, Matthias, et al.
Publicado: (2020)

The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages
por: Nakajima, Akira, et al.
Publicado: (2017)

A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
por: Deutsch, Dale G.
Publicado: (2016)

Treatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists
por: Watterson, Kenneth R., et al.
Publicado: (2014)

Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities
por: Gao, Zhumei, et al.
Publicado: (2022)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
por: Blas-García, Ana, et al.
Publicado: (2022)

Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer
por: Michalak, Arkadiusz, et al.
Publicado: (2016)

Treatment of obesity-related diabetes: significance of thermogenic adipose tissue and targetable receptors
por: Pan, Ruping, et al.
Publicado: (2023)

Curdlan intake changes gut microbial composition, short-chain fatty acid production, and bile acid transformation in mice
por: Watanabe, Keita, et al.
Publicado: (2021)

Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
por: Xu, Jingqi, et al.
Publicado: (2021)

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2018)

Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation
por: Li, Pan, et al.
Publicado: (2022)

Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression
por: Tomacha, Jittima, et al.
Publicado: (2021)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020)

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
por: Zhao, Fangyi, et al.
Publicado: (2022)

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022)

Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes
por: Bai, Litao, et al.
Publicado: (2018)

Editorial: Matricellular Receptors As Potential Targets in Anti-Cancer Therapeutic Strategies
por: Emonard, Hervé, et al.
Publicado: (2016)

Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory Disorders
por: Christian, Sherri L., et al.
Publicado: (2018)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
por: Tesch, Greg H., et al.
Publicado: (2017)

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
por: Sudhesh Dev, Sareshma, et al.
Publicado: (2021)

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
por: Dalefield, Martin L., et al.
Publicado: (2022)

Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease
por: Wang, Xue-Kai, et al.
Publicado: (2021)

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2022)

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2021)

Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
por: Wang, Mengdi, et al.
Publicado: (2022)

Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets
por: Fu, Kang, et al.
Publicado: (2022)

Targeting Gremlin 1 Prevents Intestinal Fibrosis Progression by Inhibiting the Fatty Acid Oxidation of Fibroblast Cells
por: Yang, Yang, et al.
Publicado: (2021)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
por: Zhou, Juan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t3v6to998jvne8i7lj1gsk8ib4